chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Cellulitis, Erythema, Induration, Peripheral swelling
Clinical narrative: Case number PHHY2011US115049 is an initial spontaneous report derived from Vaccine Adverse Event Reporting System web site (VAERS reference number: 429096) on 30 Sep 2011 with a follow up information received from the quality assurance department (QA reference number: 187452) on 28 Nov 2012. This case refers to a 12-year-old female patient. She was vaccinated with MENVEO vaccine (batch number: M10053) intramuscularly into her right arm on 05 Aug 2011. On the same day she was also vaccinated with BOOSTRIX (batch number: AC52B071CA) intramuscularly into her left arm, VARIVAX (other manufacturer, batch number: 0460AA) subcutaneously in her right arm and GARDASIL (other manufacturer, batch number: 0963AA) intramuscularly in her left arm. On 05 Aug 2011, she developed redness, swelling and hardness in right posterior arm. She noted this approximately 18 hours after vaccination; she also stated that redness was spreading. She had no fever and pain. She was diagnosed with cellulitis and was given treatment with BACTRIM and compresses. She had recovered completely on an unspecified date. The quality assurance department registered a complaint with reference number 187452. Based on the documents review it was stated that the concerned MENVEO batch M10053 was manufactured in accordance with the approved internal procedures and it was in compliance with the cGMP requirements. Follow up information received from the quality assurance department on 28 Nov 2012: Batch summary updated.
Sex: U
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Case number PHEH2011US00881 is an initial spontaneous report received from a consumer on 01 Aug 2011. This report refers to a patient of unknown age group and gender. This patient was vaccinated with MENVEO (batch number: unknown) intramuscularly on an unknown date. After vaccination the patient experienced fever. No further information was available. Non significant follow-up was received from the Vaccine Adverse Event Reporting System Website (VAERS Reference Number: 439968) on 07 Feb 2012. Reference number was updated. No new medical information was provided.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Case number PHHY2011US43334 is an initial spontaneous report received from a nurse on 19 May 2011. This report refers to a 14 years old female patient. She was given only the CYW-135 liquid component MENVEO vaccine (batch number 090701) intramuscularly on 13 May 2011. No other adverse reaction was reported. Non-significant follow-up received from the Vaccine Adverse Event Reporting System (VAERS ref no: 439974) on 07 Feb 2012: Updated only VAERS reference number.
Age: 24.0
Sex: M
Vaccine: MNQ
Symptoms: Back pain, Eye pain, Feeling cold, Headache, Muscle tightness
Clinical narrative: Case number PHHY2012US058221 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 444841) website on 09 Jul 2012. This report refers to 24-year-old male patient. He was vaccinated MENVEO (batch number: M10054A) in the left arm intramuscularly on 06 Dec 2011. On the same day after vaccination in the night, he complained of chills, aching muscles, back pain, headache, muscles tightening up, eyes hurting, especially while watching TV. He also experienced fever (not taken), his mother stated that it is less than 100 degrees F and advised to seek medical attention. The outcome of the events was reported as condition unchanged as of 07 Dec 2011. The causality of the event was not reported.
Age: 24.0
Sex: M
Vaccine: MNQ
Symptoms: Myalgia, Pyrexia
Clinical narrative: Case number PHHY2012US058221 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 444841) website on 09 Jul 2012. This report refers to 24-year-old male patient. He was vaccinated MENVEO (batch number: M10054A) in the left arm intramuscularly on 06 Dec 2011. On the same day after vaccination in the night, he complained of chills, aching muscles, back pain, headache, muscles tightening up, eyes hurting, especially while watching TV. He also experienced fever (not taken), his mother stated that it is less than 100 degrees F and advised to seek medical attention. The outcome of the events was reported as condition unchanged as of 07 Dec 2011. The causality of the event was not reported.
Age: 23.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Musculoskeletal pain
Clinical narrative: Case number PHHY2012US058224 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 455145) website on 09 Jul 2012. This report refers to 23-year-old female patient. She was vaccinated MENVEO (batch number: M10053), intramuscularly in the left arm, BOOSTRIX (other manufacture, batch number: AC52B074CA) intramuscularly in the left arm and HAVRIX (other manufacture, batch number: AHAVB459BB) intramuscularly in the right arm on 05 Dec 2011. On 07 Dec 2011, she called and reported that on 06 Dec 2011, she experienced left shoulder swollen and red. She was applied the cool compress. She also experienced shoulder painful. She was treated with TYLENOL and BENADRYL. On 12 Dec 2011 as per her telephone statement, soreness was better. She also took ibuprofen and has two knots on left shoulder. The outcome of the events was reported as condition unchanged as of 12 Dec 2011. The causality of the event was not reported.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Case number PHHY2012US058225 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 445146) website on 09 Jul 2012. This report refers to 13-year-old male patient. His current condition included febrile seizures, gastroesophageal reflux disease and irritable bowel syndrome. he was vaccinated MENVEO (batch number: 10054A), in the left arm on 01 Dec 2011. On 02 Dec 2011, he experienced left upper arm induration (11x7) and erythema (11X13). He was treated with ibuprofen, BENADRYL, ice and topical hydrocortisone cream. The outcome of the events was reported as recovered as of 06 Dec 2011. The causality of the event was not reported.
Age: 28.0
Sex: F
Vaccine: HEP, MMR, MNQ, TDAP, VARCEL
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Case number PHHY2012US058226 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 445392) on 09 Jul 2012. This case refers to a 28-year-old female patient whose medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M10054A) and ENGERIX-B (batch number: AHBVC004AA) intramuscularly on to left arm, MMR vaccine (other manufacturer, batch number: 0009AA) subcutaneously on to left arm and ADACEL (batch number: C3935AA) intramuscularly on to right arm and VARIVAX (batch number: 0823AA) subcutaneously on to right arm on 08 Dec 2011. On 09 Dec 2011, the following morning after vaccine administration, her left arm was itching, red and had rash with bumps. Symptoms persisted for three to four days. She applied topical hydrocortisone to affected area and began taking oral BENADRYL. The final outcome of the event was reported as complete recovery as of 14 Dec 2011.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Mobility decreased, Musculoskeletal stiffness
Clinical narrative: Case number PHHY2012US058227 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 445421) on 09 Jul 2012. This case refers to a 17-year-old female patient whose medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A10133) intramuscularly on to left arm on 05 Dec 2011. On 06 Dec 2011, she experienced stiff neck and was unable to bend. She went to emergency room and was given oral ibuprofen. The final outcome of the event was reported as condition unchanged as of 07 Dec 2011.
Age: 27.0
Sex: M
Vaccine: MNQ
Symptoms: Urticaria
Clinical narrative: Case number PHHY2012US058228 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 445457) on 09 Jul 2012. This case refers to a 27-year-old male patient whose medical history, past drugs, current condition and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A10133) intramuscularly on to right arm on 08 Nov 2011. On 09 Nov 2011, he experienced hives on body which was reported to be continuing for a week. The final outcome of the event was reported as condition unchanged as of 16 Nov 2011.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Nausea, Vomiting
Clinical narrative: Case number PHHY2011US058230 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 445517) on 09 Jul 2012. This case refers to a 17-year-old female patient whose medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO vaccine, (batch number: A10126) through unspecified route on to left arm on 06 Dec 2011. On 07 Dec 2011, 14 hours after receiving vaccine, she vomited once and was nauseated. She did not have fever. The final outcome of the event was reported as complete recovery as of 12 Dec 2011.
Age: 10.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Erythema multiforme, Peripheral swelling
Clinical narrative: Case number PHHY2012US058231 is an initial spontaneous report received  from Vaccine Adverse Event Reporting System website (VAERS reference number: 445539) on 08 JUL 2012. This case refers to a 10-year-old male patient whose medical history, past drugs and current condition were not reported. His concomitant medication included Claritin. He was vaccinated with MENVEO (batch number: A11032) intramuscularly on to right arm and BOOSTRIX (batch number: AC52B0y3BA) and FLUARIX (batch number: AFLUA658AA) intramuscularly on to left arm on 08 DEC 2011. He had swelling in right arm the day after vaccination. On 15 DEC 2011, he experience rash on chest, arms and thighs. He went to emergency room and the ras was diagnosed as erythema multiforme minor. The final outcome of the event ws reported as condition unchanged as of 15 DEC 2011.
Age: 15.0
Sex: F
Vaccine: HPVX, MNQ
Symptoms: Back pain, Blood test normal, Lipids, Metabolic function test normal, Urine analysis normal
Clinical narrative: Case number PHHY2012US058278 is an initial spontaneous report received from vaccine adverse reporting system website (VAERS reference number: 445837) on 09 Jul 2012. This case refers to a 15-year-old female patient. She was vaccinated with MENVEO vaccine (batch number: A10126) intramuscularly into her left arm on 19 Nov 2011. On the same day she was also vaccinated with human papilloma virus vaccine (other manufacturer, batch number: unknown). She stated that since vaccination she was having back pain. She had X-ray back, but the rest was not reported. She underwent comprehensive metabolic panel blood test and urinalysis; their results were within normal limits. She also had her lipid profile test but results were not reported. The outcome was reported as condition unchanged as of 20 Nov 2011. No other information was available.
Age: 15.0
Sex: F
Vaccine: HPVX, MNQ
Symptoms: X-ray
Clinical narrative: Case number PHHY2012US058278 is an initial spontaneous report received from vaccine adverse reporting system website (VAERS reference number: 445837) on 09 Jul 2012. This case refers to a 15-year-old female patient. She was vaccinated with MENVEO vaccine (batch number: A10126) intramuscularly into her left arm on 19 Nov 2011. On the same day she was also vaccinated with human papilloma virus vaccine (other manufacturer, batch number: unknown). She stated that since vaccination she was having back pain. She had X-ray back, but the rest was not reported. She underwent comprehensive metabolic panel blood test and urinalysis; their results were within normal limits. She also had her lipid profile test but results were not reported. The outcome was reported as condition unchanged as of 20 Nov 2011. No other information was available.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US058334 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 446150) website on 09 Jul 2012. This report refers to 11-year-old female patient. She was vaccinated with MENVEO (batch number: M10130), intramuscularly in the right arm and VARIVAX (other manufacture, batch number: 0782AA) subcutaneously in the right arm on 20 Dec 2011. Concomitantly she also vaccinated with VAQTA (other manufacture, batch number: 1100Y) intramuscularly in the left arm and GARDASIL (other manufacture, batch number: 1317AA) intramuscularly in the left arm on 20 Dec 2011. On 21 Dec 2011, she experienced redness, swelling, pain and induration in right upper arm. The outcome of the events was reported as recovered as of 22 Dec 2011. The causality of the events was not reported.
Age: 29.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Hyperhidrosis, Injection site pain, Injection site rash, Nasopharyngitis
Clinical narrative: Case number PHHY2012US058619 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 446318) website on 09 Jul 2012. This report refers to 29-year-old female patient. The patient was vaccinated with MENVEO (batch number: M11042) intramuscularly in the right arm on 23 Dec 2011. On 23 Dec 2011, the patient experienced fever of 102 degrees, headache, body ache, sweaty, cold approximately 8 hours after injection. These symptoms resolved on an unspecified date. The patient later complained of rash, soreness at injection site. The site appeared erythematous. The outcome of rash, soreness and erythema at injection site was not reported.
Age: 29.0
Sex: F
Vaccine: MNQ
Symptoms: Pain, Pyrexia
Clinical narrative: Case number PHHY2012US058619 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS: 446318) website on 09 Jul 2012. This report refers to 29-year-old female patient. The patient was vaccinated with MENVEO (batch number: M11042) intramuscularly in the right arm on 23 Dec 2011. On 23 Dec 2011, the patient experienced fever of 102 degrees, headache, body ache, sweaty, cold approximately 8 hours after injection. These symptoms resolved on an unspecified date. The patient later complained of rash, soreness at injection site. The site appeared erythematous. The outcome of rash, soreness and erythema at injection site was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Case number PHEH2011US06958 is an initial spontaneous report received from a health care professional on 10 Oct 2011: This report refers to a male child. He was given only the CYW-135 liquid component MENVEO vaccine (batch number: unknown) intramuscularly on 03 Oct 2011. No other adverse event was reported. Non-significant follow-up received from the Vaccine Adverse Event Reporting System (VAERS reference number: 446741) on 09 Jul 2012: Updated reference number.
Age: 15.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Case number PHEH2011US02399 is an initial spontaneous report received from a nurse on 22 Aug 2011. This report refers to a male child. He was given only the CYW-135 liquid component of MENVEO vaccine (batch number: 090901) intramuscularly on 18 Jul 2011. On the same day he was also vaccinated with BOOSTRIX vaccine (manufacturer and batch number: unknown) intramuscularly and varicella vaccine (manufacturer and batch number: unknown) subcutaneously. No other adverse reaction was reported. Non-significant follow-up received from Vaccine Adverse Event Reporting System (VAERS reference number: 446749) on 09 Jul 2012: Updated reference number.
Sex: U
Vaccine: MNQ
Symptoms: Underdose
Clinical narrative: Case number PHEH2011US04306 is an initial incomplete spontaneous report received from a nurse on 13 Sep 2011: This report refers to multiple patients of unknown age group and gender. An unknown number of patients were vaccinated with less than 0.5 ml dose of MENVEO (batch number: A10062) intramuscularly on unknown dates. No other adverse event was reported. Non-significant follow-up received from Vaccine Adverse Event Reporting System (VAERS reference number: 446753) on 09 Jul 2012: Updated reference number.
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: Case number PHEH2011US05842 is an initial spontaneous report received from a pharmacist on 30 Sep 2011. This report refers to a male patient of unknown age. He was vaccinated with MENVEO (batch number: unknown) intramuscularly in early or mid Sep 2011 (exact date unknown). The pharmacist stated that this patient received MENVEO that had been reconstituted with an expired MenA lyophilized conjugate vaccine component (expiration date: Aug 2011); the MenCYW-135 liquid conjugate vaccine component was not expired. No additional information was available, including vaccine batch number and patient identifying information at the time of this report. Non-significant follow-up received from Vaccine Adverse Event Reporting System (VAERS reference number: 446758) on 09 Jul 2012: Updated reference number.
Sex: U
Vaccine: MNQ
Symptoms: No adverse event, Product preparation error
Clinical narrative: Case number PHEH2011US04984 is an initial spontaneous report received from a nurse on 22 Sep 2011. This case refers to an adult patient of unknown gender. The patient was received only the MenA lyophilized conjugate component of MENVEO vaccine (batch number: M100034) that was reconstituted with a sterile diluent, intramuscularly on unspecified date. No adverse reaction had occurred following this drug administration error. Non-significant follow-up received from Vaccine Adverse Event Reporting System (VAERS reference number: 446766) on 09 Jul 2012: Updated reference number.
Age: 23.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: Injection site swelling, Injection site warmth, Malaise
Clinical narrative: Case number PHHY2012US017126 is an initial spontaneous report received from VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS: 447081) website on 29 Feb 2012. This report refers to 23-year-old female patient. Her medical history and concomitant medication was not reported. The patient was vaccinated with MENVEO (batch number: M10124) intramuscularly in left arm and HEP (batch number:  AHBVB945CB) intramuscularly in right arm on 14 Dec 2011. On 16 Dec 2011, she felt ill and the injection site was swollen and hot. On 17 Dec 2011, she took BENADRYL and felt better on 19 Dec 2011. She also used hot and cold pack alternatively. The outcome of the events was reported as completely recovered as of 09 Jan 2012.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Fall, Head injury, Tremor
Clinical narrative: Case PHHY2012US017127 is an initial spontaneous case received from Vaccine Adverse Event Reporting System (VAERS Ref: 447104) website on 29 Feb 2012. This report refers to a 14-year-old female patient whose medical history and concomitant drugs were not provided. She was vaccinated with MENVEO (batch number: M10051) intramuscularly in the left arm along with diphtheria, tetanus and acellular pertussis vaccine (other manufacturer, batch number: AC52B078BA) intramuscularly on to left arm, varicella virus vaccine (other manufacturer, batch number: 1067AA) subcutaneously in left arm, hepatitis A vaccine (other manufacturer batch number AHAVB517AAA) and human papilloma virus vaccine (other manufacturer, batch number 1317AA) intramuscularly in right arm on 10 Jan 2012. On the same day, after exiting the clinic she fell to the ground and hit back of her head. She experienced full body tremors which lasted for less than 60 seconds. She woke and asked what had happened to her. Comfort measures were provided and she was transported to local emergency room. The outcome was reported as complete recovery as of 10 Jan 2012. The causality was not reported.
Age: 19.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Chest pain, Decreased appetite, Headache, Insomnia, Pyrexia
Clinical narrative: Case number PHHY2012US017105, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS Ref: 447276) website on 29 Feb 2012 with the following internal review done on 07 Apr 2012 of data received on 29 Feb 2012. This report refers to 19-year-old female patient. Her medical history included asthma and she was also allergic to Sulfa, Penicillin, LORTAB and BENADRYL. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A10130), intramuscularly in the left arm and HPV vaccine (other manufacture, batch number: 0597Z) intramuscularly in the right arm on 10 Jan 2012 at 3:00 PM. On 10 Jan 2012, at 7:30 p.m. she experienced headache, loss of appetite, fever 101 degree Celsius, had trouble sleeping and chest pains. She said that, fever was down to 99 degree Celsius on 11 Jan 2012 but was still having chest pain. Nurse advised her to family to take the local emergency room. The outcome of the events was reported as condition unchanged as of 11 Jan 2012. Following internal review done on 07 Apr 2012 of data received on 29 Feb 2012, the following correction had been done: Changed the labeling of appetite lost from listed to unlisted.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site discolouration, Injection site erythema, Pain, Paraesthesia
Clinical narrative: Case number PHHY2012US017139 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS ref: 447295) web site on 29 Feb 2012. This report refers to 25-year-old female patient. Her medical history was not provided and her concomitant medications included phentermine and APRI. She was vaccinated with MENVEO (batch number: X11033) intramuscularly in left arm on 10 Jan 2012. On 11 Jan 2012 she had little pink area around the injection. It was reported that the area began to turn red or blue and that she experienced tingling and soreness. The patient went to emergency room. The ultrasound confirmed no blood clot. She was treated with VICODIN and MOTRIN. The outcome of the events was reported as complete recovery as of 12 Jan 2012.
Age: 29.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Case number PHHY2012US038117, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 447754) website on 07 May 2012. This report refers to a 29-year-old male patient. He was vaccinated with MENVEO (batch number: M11045), intramuscularly on 04 Jan 2012. On 08 Jan 2012, he experienced rash and redness at the site of injection. Outcome of the events was reported as condition unchanged as of 19 Jan 2012. The causality of the event was not reported.
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Case number PHHY2012US038118, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 447755) website on 07 May 2012. This report refers to a female patient of unknown age. She was vaccinated with MENVEO (batch number: M11042), intramuscularly on 04 Jan 2012. On 08 Jan 2012, she experienced rash and redness at the site of injection. Outcome of the events was reported as condition unchanged. The causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Left upper arm showed redness (4 inches x2 inch), pain, swelling and itching. (Vaccination site pruritus) Case number PHHY2012US038123, is an initial report received from the Vaccine Adverse Event Reporting System (reference number: 447786) website on 07 May 2012. This report refers to a 11-years-old female patient. She was vaccinated with MENVEO (batch number: M11041), intramuscularly in the right arm on 19 Jan 2012. In the afternoon on 20 Jan 2012, left upper arm showed redness (4 inch x2 inch), pain, swelling and itching. She stated that, these symptoms persisted throughout the weekend with some numbness of the arm. Outcome of the events was reported as condition unchanged as of 23 Jan 2012. The causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Cold sweat, Dizziness, Vertigo
Clinical narrative: Case number PHHY2012US038152, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 448164) web site on 07 May 2012. This report refers to an 11-years-old male patient. At the age of 10-years-old, he was vaccinated with Varicella vaccine (manufacture: unknown) and experienced severe injection site swelling accomplished by heat. He was vaccinated with MENVEO (batch number: unknown), in the left arm on 26 Jan 2012. On 27 Jan 2012, he woke up and felt extreme dizziness, room spinning and cold clammy to touch. Outcome of the events was reported as recovered as of 27 Jan 2012. The causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: FLU3, HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US038288 is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 448441) on 07 MAY 2012. This report refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: A10051) intramuscularly along with GARDASIL (batch number: 0477AA)  intramuscularly into the left arm and with FLUZONE (other manufacturer, batch number: UH506AB) intramuscularly along with BOOSTRIX (other manufacturer, batch # AC52B069FA) intramuscularly into the lft arm on 13 FEB 2012. On the same day after vaccination he experienced itching, redness, swelling and warm to touch on and around area  of injection. Left arm measured approximately 5 inches x 5 inches and right arm measured 3.5 inches  x 3.5 inches. Patient developed reaction on both arms, but right arm had a central clearing. The final outcome was reported as complete recovery of the patient on an unknown date. No further information  was available.
Age: 14.0
Sex: M
Vaccine: FLU3, HPV4, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US038179 is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 448449) on 07 MAY 2012. This report refers to a 14-year-old male patient. He was vaccinated with MENVEO (batch number: M10065) along with FLUARIX (other manufacturer, batch number: AFLUA611AA) into the right arm and with VARCEL (other manufacturer, batch number: 0931AA) along with GARDASIL (batch number: 0840AA) into the left arm on 19 JAN 2012. On the same day after vaccination he experienced swelling, warmth and redness at the injection site on right upper deltoid area. He had to make a visit to the emergency room due to these events. The final outcome was reported as not yet recovered as on 20 JAN 2012. No further information was provided.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: Case number PHHY2012US038197, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 448576) website on 07 May 2012. This report refers to 11-years-old female patient. She was vaccinated with MENVEO (batch number: A10131), in the left arm and BOOSTRIX (other manufacture, batch number: AC52B074AA), in the right arm on 30 Jan 2012. On the same day she experienced (L) arm with large local reaction as redness, swelling and erythema is 4 in x 3 in hot to touch. The outcome of the events was reported as condition unchanged as of 02 Feb 2012. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site urticaria, Pallor
Clinical narrative: Case number PHHY2012US038216, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 448758) website on 07 MAY 2012. This report refers to an 11-years-old male patient whose medical history, past drugs, current condition and concomitant medications were unspecified., He was vaccinated with MENVEO (batch number: X10135B) and ADACEL (other manufacturer, batch number: U4308DA) intramuscularly on to right arm and FLUZONE (other manufacturer, batch number: UH487AB) intramuscularly on to left arm on 25 JAN 2012. On 26 JAN 2012, he experienced 9.5 x 6.25 cm firm, non tender erythematous related hive like lesion, blanching right deltoid. He went to emergency room. The outcome was reported as complete recovery as of 03 FEB 2012.
Age: 29.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US038227, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449167) website on 07 May 2012. This report refers to a 29-years-old female patient. Her medical history included allergic to erythromycin, AUGMENTIN and sulfonamides. She was vaccinated with MENVEO (batch number: 10126A), intramuscularly in the left arm on 31 Jan 2012. Next morning on 01 Feb 2012, she experienced a 1-2 inch red, swollen area at site of injection and pain. She was treated area with a cool compress and TYLENOL and she also took BENADRYL. Next morning on 02 Feb 2012, the redness, swelling and pain had enlarged to the entire upper (L) arm. She was consulted to a physician on 04 Feb 2012 and physician felt it was a reaction to one of the proteins in the immunization (clinic). The physician was instructed to continue TYLENOL and BENADRYL but to use a warm compress instead of a cool one. She was began to feel some relief on 05 Feb 2012 and continued to get better and since problem is now resolved.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: Case number PHHY2012US038229, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449169) website on 07 May 2012. This report refers to a 19-years-old female patient. She was vaccinated with MENVEO (batch number: M10123), intramuscularly in the left arm on 10 Jan 2012. After careful screening for last normal menstrual period (LNMP), on 19 Dec 2011 she stated that, there was no chance of pregnancy, however she states now that, she was pregnant at time of vaccination. Her prenatal care started on 10 Feb 2012 and without complaint at this time. No adverse event was reported.
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Hypoaesthesia, Injection site hypoaesthesia, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US038250, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449318) website on 07 May 2012. This report refers to a 24-years-old female patient. She was vaccinated with MENVEO (batch number M10065), intramuscularly in the right arm on 20 Dec 2011. On the same day after vaccination in the night, she noticed pain and swelling in her (R) upper arm. On, 21 Dec 11 (the next day), she noticed some numbness too her (R) shoulder and at the side of her (R) breast. She stated that, she did not do any treatment and consulted to physician. She called to the Health department on 27 Dec 2011 and advised to consult to a physician. Several attempts were made to follow up with her but did not get answer. On 09 Feb 2012, she was finally able to be reached her and stated that, problem resolved but did not consulted to the physician. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Erythema, Joint range of motion decreased, Skin warm, Swelling
Clinical narrative: Case number PHHY2012US038274, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449422) web site on 07 May 2012. This report refers to 11-years-old female patient. She was vaccinated with MENVEO (batch number: M10065), in the right arm and GARDASIL (other manufacturer, batch number: 0963AA) in the left arm on 06 Feb 2012. On 08 Feb 2012, she developed redness with mild swelling and hot to touch with decrease range of motion secondary to immunization. She was treated with KEFLEX 250 mg per tea spoon and one tea spoon QID for seven days. The outcome of the events was reported as condition unchanged as of 08 Feb 2012. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: FLU3, MNQ, TDAP, FLU3, MNQ, TDAP
Symptoms: Pruritus, Urticaria
Clinical narrative: Case number PHHY2012US03827, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449464) website on 07 MAY 2012. This report refers to 11-year-old female patient. She was vaccinated with MENVEO  (batch number M11041) intramuscularly in the right arm. FLUZONE (other manufacturer, batch number: UT14114AA) intramuscularly in the left arm on 13 FEB 2012. On the same day, she developed itching and hives within minute of receiving BOOSTRIX in (L) deltoid. She also developed hives around eyes. She was treated with two tea spoons of BENADRYL  in office and within 20 minutes hives improved with minimal itching and sent home The outcome of the events was reported as recovered as of 13 2012. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: FLU3, MNQ, TDAP, FLU3, MNQ, TDAP
Symptoms: Pruritus, Urticaria
Clinical narrative: Case number: PHHY2012US038276, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS) website on 07 MAY 2012 with the following internal review of the date received on 07 MAY 2012. This report refers to an 11-years-old female patient. She was vaccinated with MENVEO, (batch number M11041), intramuscularly in the right arm and BOOSTRIX (other manufacturer, batch number: AC52B073CA) intramuscularly in the left arm on 13 FEB 2012. On the same day she developed itching and hives within minutes of receiving BOOSTRIX in (L) deltoid. She also developed hives around eyes. She was treated with two-teaspoons of Benadryl in office and within 20 minutes hives improved with minimal itching and sent home. The outcome of the events was reported as recovered as of 13 FEB 2012. The causality of the events was not reported. Following internal review of the data received on 07 MAY 2012: Following significant correction of the events was not reported. Following internal review of the data received on 07 MAY 2012: Following significant correction was done as coded the new event itching (listed).
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: Case number PHHY2012US038287, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 449577) website on 07 May 2012. This report refers to 11-years-old male patient. His medical history included penicillin allergy. He was vaccinated with MENVEO (batch number: A10051), intramuscularly in the right arm, GARDASIL (other manufacture, batch number: 0477AA) intramuscularly in the right arm, BOOSTRIX (other manufacture, batch number: AC52B069FA), intramuscularly in the left arm and second dose of VARIVAX (other manufacture, batch number: 0448AA) subcutaneously in the left arm on 03 Feb 2012. On 04 Feb 2012, he noticed red swollen area on (R) arm and it's warm to touch. He was treated with ibuprofen and antihistamines as well and request to return the clinic if symptoms does not resolved in next one to two days. The outcome of the events was reported as recovered as of 09 Feb 2012. The causality of the events was not reported.
Age: 40.0
Sex: M
Vaccine: MEN, MNQ
Symptoms: Back pain, Computerised tomogram, Fatigue, Full blood count, Headache
Clinical narrative: Case number PHHY2012US038293 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 449811) website on 07 May 2012. This report refers to a 40-years-old male patient whose medical history and current condition were not reported. His past drug included codeine and concomitant medications were unspecified. He was vaccinated with MENVEO (batch number: not reported) through unspecific route and site and MENOMUNE (other manufacturer, batch number: not reported) through systemic route on to left arm on 11 Feb 2012. On 14 Feb 2012, he experienced severe tingling in back arms, legs and neck and pain in head and back with nausea and fatigue. He went to emergency room and CAT scan and complete blood count was performed. The outcome was reported as condition unchanged as of 19 Feb 2012.
Age: 40.0
Sex: M
Vaccine: MEN, MNQ
Symptoms: Nausea, Paraesthesia
Clinical narrative: Case number PHHY2012US038293 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 449811) website on 07 May 2012. This report refers to a 40-years-old male patient whose medical history and current condition were not reported. His past drug included codeine and concomitant medications were unspecified. He was vaccinated with MENVEO (batch number: not reported) through unspecific route and site and MENOMUNE (other manufacturer, batch number: not reported) through systemic route on to left arm on 11 Feb 2012. On 14 Feb 2012, he experienced severe tingling in back arms, legs and neck and pain in head and back with nausea and fatigue. He went to emergency room and CAT scan and complete blood count was performed. The outcome was reported as condition unchanged as of 19 Feb 2012.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Sensation of foreign body
Clinical narrative: Case number PHHY2012US038455, is an initial report received from the Vaccine Adverse Event Reporting System (reference number: 450200) website on 07 May 2012. This report refers to 12-years-old female patient. Her medical history included asthma. She was vaccinated with MENVEO (batch number: M11041), subcutaneously, BOOSTRIX (batch number: 0963AA) intramuscularly on 22 Feb 2012. Within 10 minutes after vaccination, she felt sensation of globus (lump in throat). The outcome of the events was reported as recovered as of 23 Feb 2012. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MMR, MNQ, TDAP, VARCEL, HPV4, MMR, MNQ, TDAP, VARCEL
Symptoms: Cough, Eye swelling, Odynophagia, Swelling face, Throat irritation
Clinical narrative: Case number PHHY2012US038468, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 450522) website on 07 May 2012. This report refers to 11-years-old female patient. Her medical history included environmental allergies diagnosed in Dec 2011. She was vaccinated with MENVEO (batch number: A10126), in the left arm, BOOSTRIX (other manufacture, batch number: AC52B074BA), in the left arm, VARIVAX (other manufacture, batch number: 0830AA) in the left arm, GARDASIL (other manufacture, batch number: 0664Z) in the right arm and second dose of MMR II (other manufacture, batch number: 0567AA) in the right arm on 22 Feb 2012 around 4:40 pm. Within an hour of after vaccination, she experienced itchy throat, needing to cough and swallowing would hurt chest. She also experienced face and eyes swollen. She was treated with OTC BENADRYL one tablet. She went to emergency room (ER) at 6:30 p.m. and they gave a shot of BENADRYL in right hip and steroid in the left hip. The outcome of the events was reported as recovered as of 24 Feb 2012. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Case number PHHY2012US038474 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 450842) on 07 May 2012. This case refers to an 11-year-old male patient. He was vaccinated with MENVEO vaccine (batch number: A10062) into his right arm on 28 Feb 2012. On the same day he was also vaccinated with ADACEL vaccine (other manufacturer, batch number: U3956AA) and VARIVAX (other manufacturer, batch number: 0337AA) into his right arm. On 28 Feb 2012, after vaccination he experienced redness, tenderness and pain at the injection site. On 29 Feb 2012 he had an emergency doctor visit and he was prescribed BENADRYL as necessary. He had recovered completely on an unspecified date.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Immediate post-injection reaction, Vomiting
Clinical narrative: Case number PHHY2012US038478 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 450913) on 07 May 2012. This case refers to a 17-year-old female patient. She was currently recovering from upper respiratory illness. She was vaccinated with MENVEO (batch number: A10055) intramuscularly into her left arm on 28 Feb 2012. On the same day she was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B073BA) intramuscularly into her left arm, HAVRIX (other manufacturer, batch number: AHAVB539CA) intramuscularly into her right arm and GARDASIL (other manufacturer, batch number: 1359AA) intramuscularly into her right arm. She began vomiting immediately post vaccine administration and continued through night. She had recovered completely on an unspecified date.
Age: 1.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2012US038482 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 451206) on 07 May 2012. This case refers to 1-year-old male patient. He was vaccinated with MENVEO (batch number: M10126S) intramuscularly into his right arm on 29 Feb 2012. On the same day he was also vaccinated with ADACEL (other manufacturer, batch number: U4104BA) intramuscularly into his right arm, and GARDASIL (other manufacturer, batch number: 0692AA) intramuscularly into his left arm. On 02 Mar 2012 he developed redness and swelling at the injection site (no information about which arm). He had an emergency doctor visit due to these events. The outcome of these events was reported as condition unchanged.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Dyspnoea, Erythema, Fatigue, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2012US038494 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 451320) on 07 May 2012. This case refers to a 19-year-old female patient. She was vaccinated with MENVEO (batch number: M10126A) intramuscularly into her left arm on 10 Jan 2012. On the same day after vaccination she had heavy breathing and felt tired. She went home to bed. Next morning she went to work and her arm felt hot. After nine hours shift she went home, taking off shirt and found that her left arm was extremely swollen, hot and red. The red was appearing in her arm as if something was poured on it and it was running down unevenly, like streaking she assumed.  She then took BENADRYL and it took approximately 4 days to resolve. She had recovered completely.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Case number PHHY2012US038503 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 451453) on 07 May 2012. This case refers to an 11-year-old male patient. His medical history included of apnea at birth. He was vaccinated with MENVEO (batch number: M10133) intramuscularly into his left arm on 07 Mar 2012. On the same day he was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B072EA) intramuscularly into his right arm. On 08 Mar 2012 he developed three inch diameter redness in his left deltoid that was firm, hot and very painful. On 08 Mar 2012 in the evening he went with his father to emergency room where he was given cold compression and ALLEGRA. The outcome of the events was reported as condition unchanged.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Antinuclear antibody negative, Back pain, Borrelia test negative, C-reactive protein normal, Cytomegalovirus test negative
Clinical narrative: Case number PHHY2012US048099 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 452066) website on 06 Jun 2012. This report refers to a 17-years-old female patient whose current condition included reflux. Her concomitant medications included omeprazole. She was vaccinated with MENVEO (batch number: A10060) and HAVRIX (other manufacturer, batch number: AHAVB549BA) intramuscularly on to right arm and GARDASIL (other manufacturer, batch number: 1560AA) intramuscularly on to left arm on 24 Feb 2012. On 29 Feb 2012, she experienced fever, back pain and neck pain. She was treated with NAPROSYN. On 12 Mar 2012, she experienced back pain, joint pain, fatigue and swollen lymph nodes on neck. Diagnostic laboratory tests were ordered on 12 Mar 2012 and Epstein-Barr virus (EBV) test, Cytomegalovirus (CMV) titer, Antinuclear antibody (ANA), C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), Lyme titer and Comprehensive Metabolic Panel (CMP) were done. The outcome was reported as complete recovery. All test results were reported to be normal. On 16 Mar 2012, the patient's parent reported that she experienced arm pain and numbness and rheumatologist referral was made. The outcome was reported as condition unchanged.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Epstein-Barr virus test negative, Fatigue, Hypoaesthesia, Lymphadenopathy, Metabolic function test normal
Clinical narrative: Case number PHHY2012US048099 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 452066) website on 06 Jun 2012. This report refers to a 17-years-old female patient whose current condition included reflux. Her concomitant medications included omeprazole. She was vaccinated with MENVEO (batch number: A10060) and HAVRIX (other manufacturer, batch number: AHAVB549BA) intramuscularly on to right arm and GARDASIL (other manufacturer, batch number: 1560AA) intramuscularly on to left arm on 24 Feb 2012. On 29 Feb 2012, she experienced fever, back pain and neck pain. She was treated with NAPROSYN. On 12 Mar 2012, she experienced back pain, joint pain, fatigue and swollen lymph nodes on neck. Diagnostic laboratory tests were ordered on 12 Mar 2012 and Epstein-Barr virus (EBV) test, Cytomegalovirus (CMV) titer, Antinuclear antibody (ANA), C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), Lyme titer and Comprehensive Metabolic Panel (CMP) were done. The outcome was reported as complete recovery. All test results were reported to be normal. On 16 Mar 2012, the patient's parent reported that she experienced arm pain and numbness and rheumatologist referral was made. The outcome was reported as condition unchanged.